Pharma Focus America

Pharma Focus America Welcome to Pharma focus America! We bring you the latest insights, innovations, and news from the world of pharmaceuticals. Ltd..

Join our community to stay updated and engage with industry experts! About Pharma Focus America:
Pharma Focus Aerica is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies. Pharma Focus America covers important issues and trends shaping the futu

re of the pharma industry across America and rest of the world. Pharma Focus America offers . . .
• Dedicated, reliable and accurate coverage of the industry’s progress and
• Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:
• Strategy
• Research and Development
• Manufacturing
• Clinical Trials
• Information Technology

The one-stop pharma destination www.pharmafocusamerica.com features complete content from the Pharma Focus America magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership
The magazine’s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on America, Pharma Focus America reaches out to the key industry leaders across America, Europe and the Asia.

The GLP-1 era is redefining obesity treatment — and safety surveillance is under pressure to keep up.Vasudev Bhupathi, D...
26/05/2026

The GLP-1 era is redefining obesity treatment — and safety surveillance is under pressure to keep up.

Vasudev Bhupathi, Director of Pharmacovigilance at Moderna, discusses the growing importance of:
✔️ Real-world evidence (RWE)
✔️ AI-supported pharmacovigilance
✔️ Monitoring compounded obesity medicines
✔️ Clearer safety communication

In a high-demand therapeutic space, trust, transparency, and rapid safety action matter more than ever.

Visit our website to read the full discussion: https://www.pharmafocusamerica.com/expert-talk/pharmacovigilance-in-the-glp-1-era

Speed is driving today’s oligonucleotide programs—but speed without a strong CMC strategy can create major challenges la...
21/05/2026

Speed is driving today’s oligonucleotide programs—but speed without a strong CMC strategy can create major challenges later.

In Pharma Focus America – Issue 07, pharmaceutical leaders David Butler (Hongene), Lucia Kovac (Ofichem), and Xufeng Sun (Sharp) discuss how the industry is balancing rapid development timelines, regulatory expectations, manufacturing scalability, and analytical readiness in increasingly complex oligonucleotide therapeutics.

This conversation goes beyond theory and highlights the practical realities sponsors face every day:
🔹 Impurity control at scale
🔹 Tech transfer risks during manufacturing scale-up
🔹 Regulatory expectations for early IND submissions
🔹 Supply-chain resilience and raw material challenges
🔹 The importance of fit-for-purpose analytical methods

Moderated by Sarah Richards, the panel delivers valuable perspectives for pharmaceutical and biotech professionals working across development, manufacturing, and regulatory functions.

Download the latest issue of Pharma Focus America: https://www.pharmafocusamerica.com/magazine

Read the full expert article today: https://www.pharmafocusamerica.com/expert-talk/oligonucleotide-cmc-and-manufacturing

3D biology research deserves imaging that keeps up with the complexity of the model.Our new white paper shows how confoc...
20/05/2026

3D biology research deserves imaging that keeps up with the complexity of the model.

Our new white paper shows how confocal live-cell imaging helps researchers generate clearer visualization and stronger quantitative data while keeping cultures protected inside the incubator.

From spheroids and organoids to immune co-cultures, continuous monitoring makes it easier to follow cellular changes, treatment effects, and interactions over time—without interrupting the experiment.

If your team is focused on improving confidence in long-term 3D studies, this resource is built for you.

Download the white paper now: https://industry.pharmafocusamerica.com/clientemailblast/1779096486-Sartorius.html

Can microbiome data truly deliver clinically actionable insights?The latest Issue 07 of Pharma Focus America brings toge...
19/05/2026

Can microbiome data truly deliver clinically actionable insights?

The latest Issue 07 of Pharma Focus America brings together leading experts Pablo Yarza, Adriel Latorre, and Carmen Martin, with moderator Maryam Daneshpour, PhD, MBA, to discuss the real opportunities and bottlenecks shaping microbiome and microbial omics research.

From data quality and sequencing limitations to AI-driven bioinformatics, biomarker validation, and regulatory concerns, this expert discussion highlights the key challenges pharma and biotech companies must overcome to move microbiome innovation forward.

One major takeaway: Strong data governance, standardisation, and clinically validated workflows are becoming essential for successful microbiome-based therapeutics and diagnostics.

Read the full discussion in the latest magazine issue:
https://www.pharmafocusamerica.com/expert-talk/microbiome-and-microbial-omics-data

Download now and stay updated with the latest pharma and biotech insights: https://www.pharmafocusamerica.com/magazine

The future of pharma is moving from disconnected systems to intelligent AI orchestration.In an exclusive discussion, Dr....
18/05/2026

The future of pharma is moving from disconnected systems to intelligent AI orchestration.

In an exclusive discussion, Dr. Darko Matovski, CEO of causaLens, highlights how multi-agent AI architectures are helping pharmaceutical companies connect clinical trials, safety monitoring, compliance, and post-market surveillance.

Instead of teams working in silos, AI-powered digital workers can automate complex workflows while maintaining transparency, compliance, and human oversight.

What this means for pharma organizations:
✔ Reduced manual effort
✔ Faster regulatory readiness
✔ Improved adverse event reporting
✔ Real-time decision support
✔ Enhanced patient safety monitoring

AI is no longer just supporting pharma operations — it’s becoming a strategic workforce partner.

Read the complete interview on our website and see how AI is shaping the next era of pharmaceutical innovation: https://www.pharmafocusamerica.com/expert-talk/from-clinical-trials-to-pharmacovigilance

We have two exclusive offers for 𝐂𝐡𝐞𝐦𝐄 𝐒𝐡𝐨𝐰 𝟐𝟎𝟐𝟔 𝐏𝐨𝐰𝐞𝐫𝐞𝐝 𝐛𝐲 𝐀𝐂𝐇𝐄𝐌𝐀, 𝐉𝐮𝐧𝐞 𝟗-𝟏𝟎 at the 𝐆𝐞𝐨𝐫𝐠𝐞 𝐑. 𝐁𝐫𝐨𝐰𝐧 𝐂𝐨𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐂𝐞𝐧𝐭𝐞𝐫 i...
15/05/2026

We have two exclusive offers for 𝐂𝐡𝐞𝐦𝐄 𝐒𝐡𝐨𝐰 𝟐𝟎𝟐𝟔 𝐏𝐨𝐰𝐞𝐫𝐞𝐝 𝐛𝐲 𝐀𝐂𝐇𝐄𝐌𝐀, 𝐉𝐮𝐧𝐞 𝟗-𝟏𝟎 at the 𝐆𝐞𝐨𝐫𝐠𝐞 𝐑. 𝐁𝐫𝐨𝐰𝐧 𝐂𝐨𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐂𝐞𝐧𝐭𝐞𝐫 in 𝐇𝐨𝐮𝐬𝐭𝐨𝐧.

Use code 𝐂𝐇𝐄𝐌𝐄𝟐𝟓𝐌𝐏 for 25% off the full delegate rate, or use code 𝐂𝐇𝐄𝐌𝐄𝐌𝐏𝐄𝐗𝐏𝐎 for complimentary exhibit hall access.

The two-day program covers chemicals, pharmaceutical and biopharma manufacturing, hydrogen, sustainability, digital transformation, and lab innovation, with keynotes from ExxonMobil, Johnson & Johnson, and Deloitte and more than 100 technology exhibitors on the floor.

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐚𝐭 www.cheme-show.com/registration.

𝐂𝐡𝐞𝐦𝐄 𝐒𝐡𝐨𝐰 𝟐𝟎𝟐𝟔 | 𝐉𝐮𝐧𝐞 𝟗-𝟏𝟎 | 𝐇𝐨𝐮𝐬𝐭𝐨𝐧, 𝐓𝐞𝐱𝐚𝐬

Working with primary hepatocytes requires consistency, precision, and the right scientific approach. Small improvements ...
15/05/2026

Working with primary hepatocytes requires consistency, precision, and the right scientific approach. Small improvements in handling and culture conditions can significantly enhance viability, metabolic stability, and data reliability.

Lonza’s Hepatocyte Bench Guide for Drug Development Applications is designed to support researchers with practical, easy-to-apply insights across drug metabolism, toxicity testing, and DDI studies.

Inside you’ll find guidance on:
✔ Choosing the right hepatocyte format
✔ Improving plating and attachment success
✔ Reducing variability in experimental outcomes

Better in vitro liver models start with better preparation.

👉Access the guide and connect with our scientific experts: https://industry.pharmafocusamerica.com/clientemailblast/1778763557-Lonza-Biosciences.html

Manual ADC aliquoting doesn’t just take time—it adds complexity, risk, and heavy operator workload.An Irish manufacturer...
15/05/2026

Manual ADC aliquoting doesn’t just take time—it adds complexity, risk, and heavy operator workload.

An Irish manufacturer improved this critical step using the automated RoSS.FILL platform, reshaping how fill-finish preparation is done.

The impact was clear:
• ~90% reduction in labor hours
• Fewer manual steps, stronger operator safety
• More consistent GMP-compliant results (EU GMP Annex 1)

This is what happens when automation meets real production challenges—efficiency and compliance move together.

See the ROI impact: https://industry.pharmafocusamerica.com/clientemailblast/1778578823-Single-Use-Support.html

The new Pharma Focus America newsletter just landed, and honestly, it's packed with the kind of content that makes you f...
15/05/2026

The new Pharma Focus America newsletter just landed, and honestly, it's packed with the kind of content that makes you feel truly plugged into the industry.

We're talking exclusive interviews with people shaping the sector, techno trends that are quietly transforming manufacturing, and research insights you might have missed during a busy week. Plus, there’s a fresh podcast episode and the latest magazine issue ready for your weekend reading.

This is the resource to share with colleagues who care about staying informed without sifting through endless noise. Whether you're tracking clinical developments or industrial projects, the roundup is solid.

https://industry.pharmafocusamerica.com/e-newsletters/1778669429-Pharma-Focus-America-May-26.html

Dive into the complete issue and subscribe here: https://www.pharmafocusamerica.com/e-newsletter-subscribe

Running global clinical trials is becoming more complex — but the right regional strategy can make all the difference.Wh...
14/05/2026

Running global clinical trials is becoming more complex — but the right regional strategy can make all the difference.

Why are more sponsors looking toward JAPAC?
✔️ Faster development timelines
✔️ Improved patient recruitment opportunities
✔️ Regulatory progress in Japan
✔️ Rapid early-phase capabilities in China & Australia
✔️ Strong local expertise backed by global delivery teams

IQVIA’s JAPAC experts will be in the United States from May 29 – June 4 to connect with partners and discuss how JAPAC can support stronger, faster clinical development outcomes.

📅 Register before May 30, 2026, to arrange a meeting:
https://industry.pharmafocusamerica.com/clientemailblast/1778587202-IQVIA.html

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

Alerts

Be the first to know and let us send you an email when Pharma Focus America posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category